1) Ikeda S, Takahashi H, Suga Y, et al:Therapeutic depletion of myeloid lineage leukocytes in patients with generalized pustular psoriasis indicates a major role for neutrophils in the immunopathogenesis of psoriasis. J Am Acad Dermatol 2013;68:609-17 2) Kanekura T, Yoshii N, Yonezawa T, et al:Treatment of pustular psoriasis with granulocyte and monocyte adsorption apheresis. J Am Acad Dermatol 2003;49:329-32 3) Kanekura T, Hiraishi K, Kawahara K, et al:Granulocyte and monocyte adsorption apheresis (GCAP) for refractory skin diseases caused by activated neutrophils and psoriatic arthritis:evidence that GCAP removes Mac-1-expressing neutrophils. Ther Apher Dial 2006;10:247-56 4) Sakanoue M, Takeda K, Kawai K, Kanekura T:Granulocyte and monocyte adsorption apheresis for refractory skin diseases due to activated neutrophils, psoriasis, and associated arthropathy. Ther Apher Dial 2013;17:477-83 5) Seishima M, Mizutani Y, Shibuya Y, et al:Efficacy of granulocyte and monocyte adsorption apheresis for pustular psoriasis. Ther Apher Dial 2008;12:13-8 6) Shukuya R, Hasegawa T, Niwa Y, et al:Granulocyte and monocyte adsorption apheresis for generalized pustular psoriasis. J Dermatol 2011;38:1130-4 7) Fujisawa T, Suzuki S, Mizutani Y, et al:Granulocyte and monocyte adsorption apheresis for generalized pustular psoriasis:therapeutic outcomes in three refractory patients. Ther Apher Dial 2015;19:336-41
